Natus to Participate in Raymond James Virtual Human Health Innovation Conference
Natus Medical Incorporated (NASDAQ: NTUS) announced its participation in the Raymond James Virtual Human Health Innovation Conference on June 16, 2020.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Natus Medical Incorporated (NASDAQ: NTUS) announced its participation in the Raymond James Virtual Human Health Innovation Conference on June 16, 2020. CEO Jonathan Kennedy and CFO Drew Davies will hold one-on-one meetings with institutional investors. Interested investors can schedule meetings through a Raymond James representative. Natus specializes in medical device solutions for diagnosing and treating central nervous and sensory system disorders across all ages.
Details
News Market Reaction – NTUS
The recorded move for NTUS in the trading session of this news was +0.69%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PLEASANTON, Calif., June 11, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced that Jonathan Kennedy, President and Chief Executive Officer and Drew Davies, Executive Vice President and Chief Financial Officer will be hosting one-on-one meetings with institutional investors at the Raymond James Virtual Human Health Innovation Conference on Tuesday, June 16th. Investors interested in scheduling a meeting should contact a Raymond James representative.
About Natus Medical Incorporated
Natus is a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages.
Additional information about Natus Medical can be found at www.natus.com.
Natus Medical Incorporated
B. Drew Davies
Executive Vice President and Chief Financial Officer
(925) 223-6700
InvestorRelations@Natus.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.